Tempest Therapeutics, Inc. (TPST) Net income 2016–2025
Tempest Therapeutics, Inc. (TPST) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$26.3MFY2025 · since FY2016: -$82.3M → -$26.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$26.3M | +37.2% |
| FY2024 | -$41.8M | -41.9% |
| FY2023 | -$29.5M | +17.4% |
| FY2022 | -$35.7M | -26.2% |
| FY2021 | -$28.3M | -47.3% |
| FY2020 | -$19.2M | +56.9% |
| FY2019 | -$44.6M | -63.9% |
| FY2018 | -$27.2M | +67.8% |
| FY2017 | -$84.6M | -2.8% |
| FY2016 | -$82.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice